Therapy is aimed at identification/elimination of triggers, if present, and advancement on the skin barrier by way of topical creams and ointments. In a very section 2 trial, 6 subcutaneous injections at intervals of 1-two months of allergen-CpG ODN-loaded virus-like particles, when presented to sufferers with allergic rhinoconjunctivitis, were po